Cell models are replacing animal testing in pharma. Explore expert tips on transitioning to more accurate, ethical and scalable alternatives.

The move comes after the Food and Drug Administration announced its own plans to reduce and possibly replace animal testing in drug development.

Dr. Nicole Kleinstreuer joins NIH Director Dr. Jay Bhatt to discuss the groundbreaking shift away from animal testing in biomedical research. With 20 years of experience leading scientific ...

” This document marks the inaugural publication in a new series of ICCS Best Practice Guidance documents, developed to support the global transition to animal-free safety science.

Urgent call to eliminate animal studies and establish clear guidelines for affordable biosimilars, ensuring safety and efficacy.

The U.S. Food and Drug Administration (FDA) announced a landmark decision on April 10, 2025, phasing out mandatory animal testing for drugs such as monoclonal antibodies. This revolutionary ...

While anti-animal testing groups condemn "deadly" dog and cat studies as morally wrong, the NIH defended certain experiments as "well-justified and responsible." ...

NGOs ask DCGI to eliminate unnecessary animal studies, clarify clinical trial conditions in biosimilar guidelines ...

NEW YORK, July 22, 2025--The International Collaboration on Cosmetics Safety (ICCS) announces its first-ever Best Practice Guidance (BPG): "Skin Sensitization Assessment: Using New Approach Methods ...

These guidance documents will continue to support ICCS' goal of equipping the international community with practical tools for modern, human-relevant, and animal-free safety assessments.